University of Wisconsin–Madison Medical College of Wisconsin

Lead Exposure Risk and Testing for Pregnant People in Milwaukee

Anne Getzin, MD; Jessica J. F. Kram, MPH; James O. Adefisoye, MS, PhD; Diana Kleber, RN; Lauren Oberbroeckling, DO

WMJ. 2024;123(6):487-491.

Download full-text pdf.

ABSTRACT

Background: Despite established lead exposure risks in Milwaukee from leaded water service lines and lead dust exposure with aged housing stock, most pregnant people do not have lead levels tested. We aimed to assess the prevalence of elevated lead levels among pregnant people and assess for differences in maternal and neonatal outcomes by lead detection.

Methods: We conducted a prospective, longitudinal study. English-speaking pregnant people ≥18 years of age receiving prenatal care were consented to receive a point-of-care (POC) lead test from June 2019 through July 2021. POC lead testing was not offered outside of the study. Venous lead labs were ordered to confirm elevated POC results (≥5 mcg/dL).

Results: Overall (n=233), 42.1% had an exposure risk given lead service line to their homes. Nine (3.9%) had an elevated POC lead test; half completed venous lead tests, and none were elevated. Twenty-two (9.4%) had detectable lead (≥3.3 mcg/dL).

Discussion: Venous lead testing should be considered in high-risk areas with standard prenatal labs to facilitate effective lead screening given the study population’s risk of lead exposure.


Author Affiliations: Department of Family Medicine, Aurora University of Wisconsin Medical Group, Advocate Health, Aurora Midtown, Milwaukee, Wisconsin (Getzin); Academic Affairs, Aurora University of Wisconsin Medical Group, Advocate Health, Aurora Sinai Medical Center, Milwaukee, Wisconsin (Kram, Adefisoye); Center for Urban Population Health, Milwaukee, Wisconsin (Kram); Advocate Aurora Research Institute, Milwaukee, Wisconsin (Kleber); Department of Family Medicine, Advocate Health, Aurora St. Luke’s Medical Center, Milwaukee, Wisconsin (Oberbroeckling).
Corresponding Author: Anne Getzin, MD, 5818 W Capitol Dr, Milwaukee WI 53216; phone 715.212.2830; email anne.getzin@aah.org; ORCID ID 0009-0007-7482-2727
Financial Disclosures: None declared.
Funding/Support: This project was internally funded by the Milwaukee Clinical Faculty Fund.
Previous Presentations: Some of this work was submitted as an abstract for presentation at the 2022 American Public Health Association annual meeting on November 6-9, 2022, in Boston, Massachusetts. Some of this work was also presented internally.
Share WMJ